- DocumentConvenience Kits Interim Regulatory Guidancetéléversé parMichael wang
- DocumentClassification for OTC and RX Animal Drug Productstéléversé parMichael wang
- DocumentMedical Device Accessories Guidancetéléversé parMichael wang
- DocumentApplication User Fees for combination products.pdftéléversé parMichael wang
- DocumentFinal Rule on UDI 9-23-2013.pdftéléversé parMichael wang
- Document510(k) Format Guidance, Including Standards Form, and Extensions Clinical Trial Form and 510(k).pdftéléversé parMichael wang
- Document510 K Working Group Volume IItéléversé parMichael wang
- Document510 K Working Group Message From Center Directortéléversé parMichael wang
- DocumentGuidance for Industry Validation of Analytical Procedurestéléversé parMichael wang
- DocumentCI FDA Course PreliminaryAgenda0809[1]téléversé parMichael wang
- DocumentDo cGMP Reuired 3 Lots Validationtéléversé parMichael wang
- DocumentClass II Special Controls Guidance Document Antimicrobial Susceptibility Test (AST) Systemstéléversé parMichael wang
- DocumentSupplement and Changes to an Approved Applicationrtéléversé parMichael wang
- DocumentChamges to an Approved NDA or ANDAtéléversé parMichael wang
- DocumentTest API as USP Specificationtéléversé parMichael wang
- DocumentDraft Drug Starting Material GUidancetéléversé parMichael wang
- DocumentEVALUATING CLINICAL Studies of Antimicrobials in the Division of Antiinfective Drug Productstéléversé parMichael wang
- DocumentEvaluating the Safety of Antimicrobial New Animal Drugs.pdftéléversé parMichael wang
- DocumentFOR ORIGINAL AND SUPPLEMENTAL NEW ANIMAL DRUG APPLICATIONS.pdftéléversé parMichael wang
- DocumentFOR ORIGINAL AND SUPPLEMENTAL NEW ANIMAL DRUG APPLICATIONS.pdftéléversé parMichael wang
- DocumentClassification for OTC and RX Animal Drug products.pdftéléversé parMichael wang
- DocumentExtreme Weather Effect on Medical Device Safety and Quality.pdftéléversé parMichael wang
- DocumentEU Guideline for GMP retain samples.pdftéléversé parMichael wang
- DocumentReserve Samples.pdftéléversé parMichael wang
- DocumentCurrent Good Manufacturing Practice Requirements for Combination Products.pdftéléversé parMichael wang
- DocumentCurrent Good Manufacturing Practice Requirements for Combination Products.pdftéléversé parMichael wang
- DocumentPublic Availability of Labeling CBE guidance.pdftéléversé parMichael wang
- Document8-2012 DRaft guidance Refuse to accept policy for 510KUCM315014.pdftéléversé parMichael wang
- DocumentMedical Device Classification Guidances April 11, 2013.pdftéléversé parMichael wang
- DocumentMedical Device Classification Guidances April 11, 2013.pdftéléversé parMichael wang
- DocumentPublic Health Challenges in Influenza Diagnostics.pdftéléversé parMichael wang
- DocumentEPA for Chlorhexidine Diacetate3038redtéléversé parMichael wang
- DocumentEPA for Chlorhexidine Diacetate3038redtéléversé parMichael wang
- DocumentEUrope Cosmetic Directive 1976téléversé parMichael wang
- DocumentGuidance for Industry Validation of Analytical Procedurestéléversé parMichael wang
- DocumentGuidance for Industry Validation of Analytical Procedurestéléversé parMichael wang
- DocumentFY 2012 Small Business Qualification Guidance[1]téléversé parMichael wang
- DocumentSterile Drug Process Inspections 7356.002atéléversé parMichael wang
- DocumentFY 2012 Small Business Qualification Guidance[1]téléversé parMichael wang
- DocumentDRaft 11 2008 Process Validation FDA 2008 D 0559 Gdltéléversé parMichael wang
- DocumentProcess Valiadtion General Principles and Practices Draft Guidance 11-2008téléversé parMichael wang
- DocumentDraft Process Validation General Principle and Practices 11-2008téléversé parMichael wang